HealthPlus Retail Group – Business Plan

Investment-grade business plan for HealthPlus Retail Group (Pty) Ltd — a ZAR 2.8-billion raise to build a vertically integrated pharmaceutical retail, distribution and health-and-beauty chain in South Africa, scaling to 450+ stores and ZAR 9.2 billion revenue by Year 5 at a 26–32% IRR.

Confidential Business Plan

HealthPlus Retail Group

A vertically integrated pharmaceutical retail, distribution and health-and-beauty chain for South Africa — combining 450+ stores, three regional distribution centres and a private-label manufacturing facility — structured as an investment-grade ZAR 2.8-billion opportunity for lenders, equity investors and strategic partners.

Legal Entity
HealthPlus Retail Group (Pty) Ltd
Location
Republic of South Africa
Capital Requirement
ZAR 2.8 billion
Structure
Senior + mezzanine + equity
Stores (Yr1 → Yr5)
30 → 450+
Revenue (Yr1 → Yr5)
ZAR 340m → ZAR 9.2bn
Year 5 EBITDA Margin
17.6%
Target IRR
26–32%
Store Payback
38–44 months
Sector
Pharmaceutical & Health Retail
The Opportunity

South Africa’s pharmaceutical and health-and-beauty retail market is worth roughly R72 billion, anchored by defensive, non-discretionary demand that performs across economic cycles, yet it remains concentrated among a few incumbents. HealthPlus captures share with a vertically integrated platform — 450+ stores, three regional distribution centres and a private-label manufacturing facility — scaling from 30 stores and ZAR 340 million of revenue to 450+ stores and ZAR 9.2 billion by Year 5 at a 36.9% gross margin and 17.6% EBITDA margin, a 26–32% IRR, with each store reaching EBITDA breakeven within 14 months.

Plan Contents

This investor-grade business plan is organised into the sections below. Each section is a dedicated page — select any to explore the full detail.

Confidentiality & Disclaimer

This Business Plan (the “Document”) has been prepared by HealthPlus
Retail Group (Pty) Ltd (the “Company”) and is being furnished on a
confidential basis to a limited number of qualified institutional
investors, lenders, and strategic partners solely for the purpose of
evaluating a potential investment in, or financing of, the Company.

The information contained herein is the property of the Company and
may not be reproduced, distributed, or disclosed in whole or in part to
any third party without the prior written consent of the Company. By
accepting this Document, the recipient agrees to keep its contents
strictly confidential and to return or destroy it upon request.

Forward-Looking Statements

This Document contains certain forward-looking statements regarding
the Company’s prospects, expectations, and projected financial
performance. Such statements are based on assumptions about future
events that are inherently uncertain and subject to risks beyond the
Company’s control. Actual results may differ materially from those
projected. Recipients should not rely solely on these projections when
making any investment decision.

No Offer or Solicitation

This Document does not constitute an offer to sell or a solicitation
of an offer to buy any securities or financial instruments. Any offer or
sale of securities will be made only pursuant to definitive transaction
documents and in compliance with applicable South African and
international securities laws, including the South African Companies Act
71 of 2008, the Financial Markets Act 19 of 2012, and the listing
requirements of the JSE Limited (where applicable).

Independent Verification

Recipients are urged to conduct their own independent investigation
and analysis of the Company and the proposed transaction, including by
consulting their own legal, financial, tax, and regulatory advisers. The
Company, its directors, officers, employees, and advisers make no
representation or warranty (express or implied) as to the accuracy or
completeness of any information contained in this Document.

DOCUMENT CONTROL
Document Title HealthPlus Retail Group — Investor-Grade Business Plan
Version 1.0 — Final
Issue Date April 2026
Prepared By Office of the Chief Executive & Strategy Department
Reviewed By Board Investment Committee
Classification Strictly Confidential — Restricted Distribution
Distribution List Designated Investors, Lenders & Advisors only
Currency South African Rand (ZAR), unless otherwise stated
Reporting Standards IFRS (International Financial Reporting Standards)
Fiscal Year-End 28 February

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of HealthPlus Retail Group (Pty) Ltd.